Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A role of opening of mitochondrial ATP-sensitive potassium channels in the infarct size-limiting effect of ischemic preconditioning via activation of protein kinase C in the canine heart.
Tsukamoto O, Asanuma H, Kim J, Minamino T, Takashima S, Ogai A, Hirata A, Fujita M, Shinozaki Y, Mori H, Tomoike H, Hori M, Kitakaze M. Tsukamoto O, et al. Among authors: mori h. Biochem Biophys Res Commun. 2005 Dec 23;338(3):1460-6. doi: 10.1016/j.bbrc.2005.10.109. Epub 2005 Oct 26. Biochem Biophys Res Commun. 2005. PMID: 16271703
Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase.
Sanada S, Asanuma H, Minamino T, Node K, Takashima S, Okuda H, Shinozaki Y, Ogai A, Fujita M, Hirata A, Kim J, Asano Y, Mori H, Tomoike H, Kitamura S, Hori M, Kitakaze M. Sanada S, et al. Among authors: mori h. Circulation. 2004 Oct 12;110(15):2143-9. doi: 10.1161/01.CIR.0000143830.59419.73. Epub 2004 Sep 27. Circulation. 2004. PMID: 15451788
Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts.
Hirata A, Minamino T, Asanuma H, Sanada S, Fujita M, Tsukamoto O, Wakeno M, Myoishi M, Okada K, Koyama H, Komamura K, Takashima S, Shinozaki Y, Mori H, Tomoike H, Hori M, Kitakaze M. Hirata A, et al. Among authors: mori h. Cardiovasc Drugs Ther. 2005 Jan;19(1):33-40. doi: 10.1007/s10557-005-6895-1. Cardiovasc Drugs Ther. 2005. PMID: 15883754
H(2) mediates cardioprotection via involvements of K(ATP) channels and permeability transition pores of mitochondria in dogs.
Yoshida A, Asanuma H, Sasaki H, Sanada S, Yamazaki S, Asano Y, Shinozaki Y, Mori H, Shimouchi A, Sano M, Asakura M, Minamino T, Takashima S, Sugimachi M, Mochizuki N, Kitakaze M. Yoshida A, et al. Among authors: mori h. Cardiovasc Drugs Ther. 2012 Jun;26(3):217-26. doi: 10.1007/s10557-012-6381-5. Cardiovasc Drugs Ther. 2012. PMID: 22527618
Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
Asanuma H, Minamino T, Sanada S, Takashima S, Ogita H, Ogai A, Asakura M, Liao Y, Asano Y, Shintani Y, Kim J, Shinozaki Y, Mori H, Node K, Kitamura S, Tomoike H, Hori M, Kitakaze M. Asanuma H, et al. Among authors: mori h. Circulation. 2004 Jun 8;109(22):2773-9. doi: 10.1161/01.CIR.0000130917.12959.04. Epub 2004 May 17. Circulation. 2004. PMID: 15148268
Granulocyte colony-stimulating factor mediates cardioprotection against ischemia/reperfusion injury via phosphatidylinositol-3-kinase/Akt pathway in canine hearts.
Takahama H, Minamino T, Hirata A, Ogai A, Asanuma H, Fujita M, Wakeno M, Tsukamoto O, Okada K, Komamura K, Takashima S, Shinozaki Y, Mori H, Mochizuki N, Kitakaze M. Takahama H, et al. Among authors: mori h. Cardiovasc Drugs Ther. 2006 Jun;20(3):159-65. doi: 10.1007/s10557-006-8285-8. Cardiovasc Drugs Ther. 2006. PMID: 16775664
Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs.
Hirata A, Minamino T, Asanuma H, Fujita M, Wakeno M, Myoishi M, Tsukamoto O, Okada K, Koyama H, Komamura K, Takashima S, Shinozaki Y, Mori H, Shiraga M, Kitakaze M, Hori M. Hirata A, et al. Among authors: mori h. J Am Coll Cardiol. 2006 Jul 4;48(1):176-84. doi: 10.1016/j.jacc.2006.04.008. Epub 2006 Jun 21. J Am Coll Cardiol. 2006. PMID: 16814664 Free article.
Novel Synthesized Radical-Containing Nanoparticles Limit Infarct Size Following Ischemia and Reperfusion in Canine Hearts.
Asanuma H, Sanada S, Yoshitomi T, Sasaki H, Takahama H, Ihara M, Takahama H, Shinozaki Y, Mori H, Asakura M, Nakano A, Sugimachi M, Asano Y, Minamino T, Takashima S, Nagasaki Y, Kitakaze M. Asanuma H, et al. Among authors: mori h. Cardiovasc Drugs Ther. 2017 Dec;31(5-6):501-510. doi: 10.1007/s10557-017-6758-6. Cardiovasc Drugs Ther. 2017. PMID: 29101507
6,309 results